CONDENSED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
May 25, 2024 |
May 27, 2023 |
May 25, 2024 |
May 27, 2023 |
|||
| Income Statement [Abstract] | ||||||
| NET SALES | $ 8,063 | $ 7,443 | $ 14,181 | $ 13,632 | | |
| COST AND EXPENSES: | ||||||
| Cost of goods sold | (4,972) | (4,583) | (8,476) | (8,521) | ||
| Research and development | (549) | (625) | (1,043) | (1,277) | ||
| Selling, general and administrative expenses | (2,219) | (2,010) | (4,131) | (3,817) | ||
| Total cost and expenses | (7,740) | (7,218) | (13,650) | (13,615) | | |
| OPERATING INCOME | 323 | 225 | 531 | 17 | | |
| Interest income(expense) | (10) | (3) | (10) | 136 | | |
| Other income | 706 | 36 | 711 | 37 | | |
| Total Other Income Expenses | 696.0 | 33.0 | 701.0 | 173.0 | 0.0 | |
| INCOME BEFORE TAXES | 1,019 | 258 | 1,232 | 190 | | |
| Provision for taxes | 173 | 44 | 209 | 32 | | |
| NET INCOME | $ 846 | $ 214 | $ 1,023 | $ 158 | | |
| DIVIDENDS PER SHARE | $ 0.10 | $ 0.10 | ||||
| NET INCOME PER SHARE, BASIC | $ 0.33 | $ 0.08 | $ 0.40 | $ 0.06 | ||
| WEIGHTED AVERAGE OF SHARES, BASIC | 2,578,315 | 2,578,315 | 2,578,315 | 2,578,315 | ||
| NET INCOME PER SHARE, DILUTED | $ 0.32 | $ 0.08 | $ 0.39 | $ 0.06 | ||
| WEIGHTED AVERAGE OF SHARES, DILUTED | 2,609,509 | 2,613,965 | 2,609,509 | 2,613,965 | ||
| X | ||||||||||
- Definition Aggregate dividends paid during the period for each share of common stock outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|